Detalhe da pesquisa
1.
Mechanism of Action of KL-50, a Candidate Imidazotetrazine for the Treatment of Drug-Resistant Brain Cancers.
J Am Chem Soc
; 2024 May 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38815248
2.
The Role of PARP Inhibitors in Patients with Primary Malignant Central Nervous System Tumors.
Curr Treat Options Oncol
; 23(11): 1566-1589, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36242713
3.
Oncometabolites as Regulators of DNA Damage Response and Repair.
Semin Radiat Oncol
; 32(1): 82-94, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34861999
4.
Mechanism-based design of agents that selectively target drug-resistant glioma.
Science
; 377(6605): 502-511, 2022 07 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35901163
5.
Cediranib suppresses homology-directed DNA repair through down-regulation of BRCA1/2 and RAD51.
Sci Transl Med
; 11(492)2019 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31092693